Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Rhodes Oxycodone Tablets Recalled for Foreign Tablet Contamination

Agency Publication Date: September 13, 2021
Share:
Sign in to monitor this recall

Summary

Rhodes Pharmaceuticals, L.P. is recalling 55,344 bottles of Oxycodone Hydrochloride Tablets (10 mg) because a different medication was discovered inside a bottle. A single tablet of Hydrochlorothiazide/Lisinopril, a blood pressure medication, was found in one bottle of the prescription pain medicine. No injuries or illnesses have been reported in connection with this recall.

Risk

Taking the wrong medication can cause serious health complications, such as a sudden drop in blood pressure or adverse drug interactions. Patients expecting a pain medication who accidentally ingest a blood pressure treatment may experience unexpected side effects.

What You Should Do

  1. This recall affects 100-count bottles of Oxycodone Hydrochloride Tablets, USP, 10 mg (NDC 42858-002-01) with lot number WP5K0Y and an expiration date of 02/28/2023.
  2. If you have health concerns or believe you have experienced a reaction from this medication, contact your healthcare provider or pharmacist immediately.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact Rhodes Pharmaceuticals, L.P. for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Oxycodone Hydrochloride Tablets, USP, 10 mg (100 count bottle)
Variants: 10 mg, Tablet
Lot Numbers:
WP5K0Y (Exp 02/28/2023)
NDC:
42858-002-01

Quantity affected: 55,344 bottles. Marketed by Rhodes Pharmaceuticals L.P.; Manufactured by Purdue Pharma L.P.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88506
Status: Resolved
Manufacturer: Rhodes Pharmaceuticals, L.P.
Sold By: Pharmacies
Manufactured In: United States
Units Affected: 55,344/100 count bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.